Here are relevant reports on : herbal-medicine-market
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
North American Nuclear Medicine Market / Radiopharmaceuticals Market Size by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) & Region - Global Forecast to 2024
North american nuclear medicine market growth is primed to transition from $2.2 billion in 2019 to $2.7 billion by 2024, showcasing a strong CAGR of 4.1%. Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Europe Nuclear Medicine Market by Type (SPECT [Tc99m, I-123], PET [F-18, Rb-82], Alpha Emitters, Beta Emitters [Y-90, I-131], Brachytherapy), Application (Onco, Cardio), Procedure, End User (Imaging Center, Hospital) - Forecast to 2030
The Europe nuclear medicine market, valued at USD 2.14 billion in 2024, stood at USD 2.47 billion in 2025 and is projected to advance at a resilient CAGR of 15.8% from 2025 to 2030, culminating in a forecasted valuation of USD 5.15 billion by the end of the period. This growth is driven by the rising application of radiopharmaceuticals and radioisotopes for diagnostic imaging and targeted radionuclide therapies, especially in oncology, cardiology, and neurology. The major drivers of the demand include rising cancer incidence, the aging population, and the high adoption of the PET and SPECT procedures in key European nations.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Equipment Market by Product (Imaging: PET, SPECT, Gamma; GM Counter, Dose Calibrator), Software (Image Management, PACS, Treatment, Analytic, Workflow), Therapy (Onco, Cardio, Neuro, Ortho), End User & Region - Global Forecasts to 2030
The global nuclear medicine equipment market, valued at US$6.33 billion in 2024, stood at US$6.63 billion in 2025 and is projected to advance at a resilient CAGR of 4.62% from 2025 to 2030, culminating in a forecasted valuation of US$8.31 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Clinical Analytics Market by Offering (Raw Data, Platform), Source (EHR, Trials, Claims, RWE), Use Case (CDSS, RPM, PHM, R&D, Pharmacovigilance, Precision Medicine, Regulatory), End User (Hospital, Payer, Pharma, Medtech), Region - Global Forecast to 2030
The global clinical analytics market, valued at US$27.65 billion in 2024, stood at US$33.09 billion in 2025 and is projected to advance at a resilient CAGR of 19.7% from 2024 to 2030, culminating in a forecasted valuation of US$81.32 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
AI in Oncology Market by Player Type (Integrated Suite), Application (Drug Discovery, De Novo Drug Design, Diagnosis, Precision Medicine, Genomic), Technology (CNN, NLP), Cancer Type (Lung), End User (Hospitals, Pharma), & Region - Global Forecast to 2030
The global AI in oncology market, valued at US$1.92 billion in 2023, stood at US$2.45 billion in 2024 and is projected to advance at a resilient CAGR of 29.4% from 2024 to 2030, culminating in a forecasted valuation of US$11.52 billion by the end of the period. The AI in oncology market is experiencing significant growth due to rising investments in the pharmaceutical and biotech companies to develop potential and advance cancer drugs to reduce the growing cancer burden worldwide.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Asia Pacific Nuclear Medicine Market by Type (SPECT [Tc99m, I-123, Ga-67], PET [F-18, Rb-82], Alpha Emitters, Beta Emitters [Y-90], Brachytherapy), Application (Onco, Thyroid, Cardio), Procedure, End User (Imaging Center, Hospital) - Forecast to 2030
The Asia Pacific nuclear medicine market, valued at USD 1.82 billion in 2024, stood at USD 2.13 billion in 2025 and is projected to advance at a resilient CAGR of 17.1% from 2025 to 2030, culminating in a forecasted valuation of USD 4.68 billion by the end of the period.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Market by Type [SPECT (Tc-99m, I-123, Ga-67), PET (F-18), Alpha Emitters, Beta Emitters (Y-90, Lu-177), Brachytherapy], Application (Oncology, Cardiology, Neurology), Procedure, End User (Imaging Center, Hospital), and Region -Global Forecast to 2030
The global nuclear medicine market, valued at USD 9.03 billion in 2024, stood at USD 10.41 billion in 2025 and is projected to advance at a resilient CAGR of 15.1% from 2025 to 2030, culminating in a forecasted valuation of USD 21.01 billion by the end of the period. The growth of the market is driven by the rising prevalence of cancer and cardiovascular diseases, which is accelerating the demand for diagnostic and therapeutic radiopharmaceuticals and medical radioisotopes.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Nucleic Acid Isolation and Purification Kits Market by Type (DNA, RNA, Total Nucleic Acid, Others), Method (Column, Magnetic Beads, Reagent), Application (Diagnostics, Personalized Medicine), End User (Pharma & Biotech, CROs) – Global Forecast to 2030
The global nucleic acid isolation and purification kits market, valued at US$2.82 billion in 2024, stood at US$3.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.8% from 2025 to 2030, culminating in a forecasted valuation of US$4.82 billion by the end of the period. The growth of the nucleic acid isolation and purification kits market is mainly driven by the growth in molecular diagnostics and sequencing-based testing. Labs are running more PCR/RT-PCR panels, syndromic testing, and oncology and genetic assays. This directly aids in the growth of consumption of extraction kits across routine workflows.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) in Healthcare Market By Function (Imaging, Robotics, AI Scribe, Telehealth, CDS, Precision Medicine, Radiation, RCM, Cybersecurity), Tools (ML, NLP, Computer Vision), End User (Hospital, ASC, Payer) - Global Forecast to 2031
The global artificial intelligence in healthcare market is projected to reach USD 194.79 billion by 2031, growing at a CAGR of 39.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
